These results could be explained by the fact that miR-708 can regulate multiple genes such as c-FLIPL, survivin, ZEB2, BMI1, and CD44, which are involved in separate tumor-suppressive pathways [26, 27]. The gene discussed is CD44; the disease is neoplasm.